X
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
Other Certificates
Other Suppliers
USA (Orange Book)
0
Europe
Canada
0
Australia
0
South Africa
Uploaded Dossiers
U.S. Medicaid
0
Annual Reports
0
https://tiefenbachergroup.com/2022/09/08/new-market-launch-tiefenbacher-pharmaceuticals-successfully-launches-generic-version-of-the-diabetis-medicine-vildagliptin-and-vildagliptin-metformin-in-africa/
https://www.ema.europa.eu/en/documents/overview/vildagliptin/metformin-hydrochloride-accord-epar-medicine-overview_en.pdf
https://www.prnewswire.com/in/news-releases/glenmark-becomes-the-first-company-to-launch-remogliflozin-vildagliptin-fixed-dose-combination-at-an-affordable-price-for-adults-with-type-2-diabetes-in-india-821947177.html
https://www.business-standard.com/article/pti-stories/cipla-acquires-brand-trademark-rights-for-for-anti-diabetic-drug-vysov-in-india-119121600877_1.html
https://www.moneycontrol.com/news/business/stocks/cadila-healthcare-gains-4-on-launch-of-anti-diabetic-tablet-in-india-4722261.html
https://www.biospectrumasia.com/news/33/15053/panacea-biotec-launches-diabetes-drug-in-india.html
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/usv-in-talks-with-novartis-to-buy-jalra-trademark-for-rs-200-crore/articleshow/72431900.cms
http://www.pharmabiz.com/NewsDetails.aspx?aid=119884&sid=2
https://www.business-standard.com/article/companies/eris-lifesciences-acquires-trademark-zomelis-from-novartis-ag-for-13-mn-119120301413_1.html
https://health.economictimes.indiatimes.com/news/industry/fda-raids-traders-diverting-drugs-meant-for-defence/67860628
https://timesofindia.indiatimes.com/city/ahmedabad/novartis-restrains-local-pharma-cos-from-making-patented-diabetes-drug/articleshow/65285125.cms
http://www.pharmafile.com/news/516056/novartis-abbott-targeted-indian-watchdog-over-allegations-price-collusion
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/cci-starts-probe-on-alleged-price-fixing-of-key-anti-diabetic-drugs/articleshow/62059986.cms
http://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/anti-diabetic-drug-cartel-issue-reaches-cci-health-ministry/articleshow/57800084.cms
http://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/neobiocon-partners-novartis-to-launch-diabetes-drugs-in-uae/articleshow/50107639.cms
Market Place
Share 
